source
- Biogen seeks early-stage pipeline deals after $5.6 billion Apellis acquisitionBiogen announced it has earmarked $5.6 billion to acquire Apellis Pharmaceuticals, a move completed earlier this month. Despite the large transaction, the company says it will continue to explore…
- AstraZeneca lifts UK investment pause, pledges £300 million for new office expansionAstraZeneca announced on Wednesday that it is ending its pause on UK investment and will allocate £300 million to complete construction of a new office facility. The funding is intended to expand t…